Stroke risk modifies regional white matter differences in mild cognitive impairment

Neurobiology of Aging

Volumn 31, Issue 10, 2010, Pages 1721-1731

  Delano Wood, Lisa ^a   Bondi, Mark W ^a,b   Jak, Amy J ^a,b   Horne, Nikki R ^a   Schweinsburg, Brian C ^a,b   Frank, Lawrence R ^a,b   Wierenga, Christina E ^a   Delis, Dean C ^a,b   Theilmann, Rebecca J ^a   Salmon, David P ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Diffusion tensor imaging (DTI); Framingham; MCI; Mild cognitive impairment; Stroke risk; White matter

Indexed keywords

AGE; AGED; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; EDUCATION; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; MORPHOMETRICS; PRIORITY JOURNAL; RISK FACTOR; STROKE; VERBAL MEMORY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ANISOTROPY; COGNITION DISORDERS; COHORT STUDIES; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOENCEPHALOPATHIES; MALE; MEMORY; RISK FACTORS; STROKE;

EID: 77955844951     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.09.013     Document Type: Article

References (85)

1. Aboitz F., Rodriguez E., Olivares R., Zaidel E. Age-related changes in fibre composition of the human corpus callosum: sex differences. Neuroreport 1996, 7:1761-1764.
2. Albert M., Moss M., Tanzi R., Jones K. Preclinical prediction of AD using neuropsychological tests. J. Int. Neuropsychol. Soc. 2001, 7:631-639.
3. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1991, 1(1):103-116.
4. Barber R., Gholkar A., Scheltens P., Ballard C., McKeith I.G., O'Brien J.T. MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. Int. J. Geriatr. Psychiatry 2000, 15(10):911-916.
5. Basser P.J., Pierpaoli C. Microstuctural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B 1996, 111:209-216.
6. Bigler E.D., Tate D.F. Brain volume, intracranial volume, and dementia. Invest. Radiol. 2001, 36(9):539-546.
7. Bondi M.W., Salmon D.P., Galasko D., Thomas R.G., Thal L.J. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol. Aging 1999, 14:295-303.
8. Borroni B., Archetti S., Ferrari M., Cesana B.M., Padovani A., Regan C.E., Katona C., Walker Z., Livingston G. Relationship of vascular risk to the progression of Alzheimer's disease. Neurology 2007, 68(13):1083-1084.
9. Bozzali M., Falini A., Franceschi M., Cercignani M., Zuffi M., Scotti G., Comi G., Filippi M. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 2002, 72:742-746.
10. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 1995, 16(3):271-278.
11. Busse A., Hensel A., Guhne U., Angermeyer M.C., Riedel-Heller S.G. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006, 67:2176-2185.
12. Callen D.J., Black S.E., Gao F., Caldwell C.B., Szalai J.P. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001, 57(9):1669-1674.
13. Cho H., Yang D.W., Shon Y.M., Kim B.S., Kim Y.I., Choi Y.B., Lee K.S., Shim Y.S., Yoon B., Kim W., Ahn K.J. Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study. J. Kor. Med. Sci. 2008, 23:477-483.
14. Chui H.C., Zarow C., Mack W.J., Ellis W.G., Zheng L., Jagust W.J., Mungas D., Reed B.R., Kramer J.H., DeCarli C.C., Weiner M.W., Vinters H.V. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann. Neurol. 2006, 60(6):677-687.
15. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res. 1996, 29(3):162-173.
16. D'Agostino R.B., Wolf P.A., Belanger A.J., Kannel W.B. Stroke risk profile: adjustment for antihypertensive medication. The Framingham study. Stroke 1994, 25(1):40-43.
17. Delano-Wood L., Abeles N., Sacco J., Wierenga C.E., Horne N.R., Bozoki A. Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 2008, 39:794-800.
18. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. The California Verbal Learning Test 1987, Psychological Corporation, New York.
19. Delis D.C., Kaplan E., Kramer J.H. The Delis-Kaplan Executive Function System (D-KEFS) 2001, The Psychological Corporation, San Antonio, TX.
20. Delis D.C., Kaplan E., Kramer J.H. The Delis-Kaplan Executive Function System-Technical Manual 2001, The Psychological Corporation, New York.
21. deToledo-Morrell L., Goncharova I., Dickerson B., Wilson R.S., Bennett D.A. From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann. N Y Acad. Sci. 2000, 11:240-753.
22. deToledo-Morrell L., Stoub T.R., Bulgakova M., Wilson R.S., Bennett D.A., Leurgans S., Wuu J., Turner D.A. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol. Aging 2004, 25(9):1197-1203.
23. Dickerson B.C., Goncharova I., Sullivan M.P., Forchetti C., Wilson R.S., Bennett D.A., Beckett L.A., deToledo-Morrell L. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol. Aging 2001, 22(5):747-754.
24. Diniz B.S., Yassuda M.S., Nunes P.V., Radanovic M., Forlenza O.V. Mini-mental State Examination performance in mild cognitive impairment subtypes. Int Psychogeriatr. 2007, 19(4):647-656.
25. Du Z., Ma S., Lin R.C., Dodel F., Gao K.R., Bales L.C., Triarhou E., Chernet K.W., Perry D.L., Nelson S., Luecke L.A., Phebus F.P., Bymaster S., Paul M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:14669-14674.
26. Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999, 354:919-920.
27. Fellgiebel S., Wille P., Muller M.J., Winterer G., Scheurich A., Vucurevic G., Schmidt L.G., Stoeter P. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement. Geriatr. Cogn. Disord. 2004, 18:101-108.
28. Fellgiebel A., Dellani P.R., Greverus D., Scheurich A., Stoeter P., Muller M.J. Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus. Psychiatry Res. Neuroimaging 2006, 146:283-287.
29. Fennema-Notestine C., Ozyurt I.B., Brown G.G., Clark C.P., Morris S., Bischoff-Grethe A., Bondi M.W., Jernigan T.L., Fischl B., Segonne F., Shattuck D.W., Leahy R.M., Rex D.E., Toga A.W., Smith S.M. The human brain morphometry BIRN. Quantitative evaluation of automated skull-stripping methods applied to contemporary and legacy images: effects of diagnosis, bias correction, and slice location. Hum. Brain Mapp. 2006, 27:99-113.
30. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
31. Frank L.R. Anisotropy in high angular resolution diffusion-weighted MRI. Magn. Reson. Med. 2001, 45(6):935-939.
32. Greenaway M.C., Lacritz L.H., Binegar D., Weiner M.F., Lipton A., Cullum M.C. Patterns of verbal memory performance in mild cognitive impairment, Alzheimer's disease, and normal aging. Cogn. Behav. Neurol. 2006, 19(2):79-84.
33. Gurol M.E., Irizarry M.C., Smith E.E., Raju S., Diaz-Arrastia R., Battiglieri T. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006, 66(1):6-7.
34. Hasan K.M., Gupta R.K., Santos R.M., Wolinsky J.S., Narayana P.A. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients. J. Magn. Reson. Imaging 2004, 21:735-743.
35. Head D., Buckner R.L., Shimony J.S., Williams L.E., Akbudak E., Conturo E., McAvoy M., Morris J.C., Snyder A.Z. Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer's type: evidence form diffusion tensor imaging. Cereb. Cortex 2004, 14(4):410-423.
36. Head D., Snyder A.Z., Girton L.E., Morris J.C., Buckner R.L. Frontal-hippocampal double dissociation between normal aging and Alzheimer's disease. Cereb. Cortex 2005, 15:732-739.
37. Hofer S., Frahm J. Topography of the human corpus callosum revisited-comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. NeuroImage 2006, 32(3):989-994.
38. Huang H., Zhang J., Jiang S., Zhang J., Jiang H., Wakana S., Poetscher L., Miller M.I., van Zijl P.C.M., Hillis A.E., Wytik R., Mori S. DTI tractography based parcellation of white matter: application of the mid-sagittal morphology of corpus callosum. NeuroImage 2005, 26:295-305.
39. Jak A.J., Houston W.S., Corey-Bloom J., Nagel B.J., Bondi M.W. Differential cross-sectional and longitudianal impact of APOE genotype on hippocampal volume in nondemented older adults. Dement. Geriatr. Cogn. Disord. 2007, 23:282-289.
40. Jernigan T.L., Archibald S.L., Fennema-Notestine C., Gamst A.C., Stout J.C., Bonner J., Hesselink J.R. Effects of age on tissues of the cerebrum and cerebellum. Neurobiol. Aging 2001, 22:581-594.
41. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging 2000, 21(2):321-330.
42. Kalaria R.N. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc. Dis. 2002, 13(Suppl. 2):48-52.
43. Kantarci K., Jack C.R., Xu Y.C., Campeau N.G., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Kokmen E., Tangalos E.G., Petersen R.C. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 2001, 219:101-107.
44. Loeb P.A. Independent Living Scales Manual 1996, The Psychological Corporation, San Antonio, TX.
45. Mariani E., Monastero R., Ercolani S., Mangialasche F., Caputo M., Feliziani F.T., Vitale D.F., Senin U., Mecocci P. Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAI project. Dement. Geriatr. Cogn. Disord. 2007, 24(6):448-456. ReGAI Study Group.
46. Medina D., deToledo-Morrell L., Urresta F., Gabrieli J.D.E., Moseley M., Fleischman D., Bennett D.A., Leurgans S., Turner D.A., Stebbins G.T. White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol. Aging 2006, 27:663-672.
47. Minati L., Grisoli M., Bruzzone M.G. MR spectroscopy, functional MRI, and diffusion-tensor imaging int eh aging brain: a conceptual review. J. Geriatr. Psychaitry Neurol. 2007, 20(1):3-21.
48. Nagel B.J., Palmer S.L., Reddick W.E., Glass J.O., Helton K.J., Wu S., Xiong X., Kun L.E., Gajjar A., Mulhern R.K. Abnormal hippocampal development in children with medulloblastoma treated with resk-adapted irradiation. Am. J. Neuroradiol. 2004, 25:1575-1582.
49. Naggara O., Oppenheim C., Rieu D., Raoux N., Rodrigo S., Dalla Barba G., Meder J.F. Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res. 2006, 146(3):243-249.
50. O'Sullivan M., Jones D.K., Summers P.E., Morris R.G., Williams S.C.R., Markus H.S. Evidence for cortical 'disconnection' as a mechanism of age-related cognitive decline. Neurology 2001, 57:632-638.
51. Ota M., Obata T., Akine Y., Ito H., Ikehira H., Asada T., Suhara T. Age-related degeneration of corpus callosum measured with diffusion tensor imaging. NeuroImage 2006, 31:1445-1452.
52. Palmer K., Bäckman L., Winblad B., Fratiglioni L. Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease. Int. Psychogeriatr. 2008, 20(2):252-258.
53. Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996, 27:1641-1647.
54. Petersen R.C. Mild cognitive impairment as a diagnostic entity (key symposium). J. Intern. Med. 2004, 256:183-194.
55. Petersen R.C., Morris J.C. Mild cognitive impairment as a clinical entity and treatment target. Arch. Neurol. 2005, 62(7):1160-1163.
56. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
57. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C. Current concepts in mild cognitive impairment. Arch. Neurol. 2001, 58:1985-1992.
58. Pfefferbaum A., Sullivan E.V. Increased brain white matter diffusivity in normal adult aging: relationship to anisotropy and partial voluming. Magn. Reson. Med. 2003, 49:953-961.
59. Pfefferbaum A., Sullivan E.V., Hedehus M., Lim K.O., Adalsteinsson E., Moseley M. Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn. Reson. Med. 2000, 44:259-268.
60. Raz N. Aging of the brain and its impact on cognitive performance: integration of structural and functional findings. Handbook of Aging and Cognition 2000, Vol. 2:1-90. Erlbaum, New Jersey.
61. Raz N., Rodrigue K.M. Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci. Biobehav. Rev. 2006, 30(6):730-748.
62. Reitz C., Tang M.X., Manly J., Mayeuz R., Luchsinger J.A. Hypertension and the risk of mild cognitive impairment. Arch. Neurol. 2007, 64(12):1734-1740.
63. Rose S.E., Chen F., Chalk J.B., Zelaya F.O., Strugnell W.E., Benson M., Semple J., Doddrell D.M. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J. Neurol. Neurosurg. Psychiatry 2000, 69(4):528-530.
64. Salat D.H., Tuch D.S., Hevelone N.D., Fischl B., Corkin S., Rosas H.D., Dale A.M. Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann. N Y Acad. Sci. 2005, 1064:37-49.
65. Salmon D.P., Butters N. Neuropsychological assessment of dementia in the elderly. Principles of Geriatric Neurology 1992, 144-163. F.A. Davis Company, London distributors: Williams & Wilkins, Ltd., Philadelphia, PA. R. Katzman, J.W. Rowe (Eds.).
66. Shattuck D.W., Sandor-Leahy S.R., Schaper K.A., Rottenberg D.A., Leahy R.M. Magnetic resonance image tissue classification using a partial volume model. NeuroImage 2001, 13:856-876.
67. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17(1):87-97.
68. Smith G.E., Ivnik R.J. Normative neuropsychology. Mild Cognitive Impairment: Aging to Alzheimer's Disease 2003, 63-88. Oxford University Press, Inc., New York. R.C. Petersen (Ed.).
69. Stahl R., Dietrich O., Teipel S.J., Hampel H., Reiser M.F., Schoenberg S.T. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging nad parallel imaging techniques. Radiology 2007, 243(2):483-492.
70. Stern Y. Cognitive reserve and Alzheimer's disease. Alzheimer Dis. Assoc. Dis. 2006, 20(3 Suppl 2):S69-74.
71. Sullivan E.V., Pfefferbaum A. Diffusion tensor imaging and aging. Neurosci. Biobehav. Rev. 2006, 30(6):749-761.
72. Takahashi S., Yonezawa H., Takahashi J., Kudo M., Inoue T., Tohgi H. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0Tesla magnetic resonance imaging. Neurosci. Lett. 2002, 332:45-48.
73. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain 1988, Thieme, New York.
74. Truelsen T., Lindenstrom E., Boyesen G. Comparison of probability of stroke between the Copenhagen city heart study and the Framingham study. Stroke 1994, 25:802-807.
75. Tsivilis D., Vann S.D., Denby C., Roberts N., Mayes A.R., Montaldi D., Aggleton J.P. A disproportionate role for the fornix and mammillary bodies in recall versus recognition memory. Nat. Neurosci. 2008, 11(7):834-842.
76. Ukmar M., Makuc E., Onor M.L., Garbin G., Trevisiol M., Cova M.A. Evaluation of white matter damage in patients with Alzhiemer's disease and in patients with mild cognitive impairment by using diffusion tensor imaging. Neuroradiology 2007, 14:201-208.
77. Wechsler D. Wechsler Intelligence Scale for Children-Revised 1974, Psychological Corporation, New York.
78. Wechsler D. Wechsler Adult Intelligence Scale-Revised Manual 1981, The Psychological Corporation, San Antonio.
79. Wechsler D. Wechsler Memory Scale-Revised 1987, Psychological Corporation, New York.
80. Welsh K., Butters N., Mohs R.C. CERAD part V: a normative study of the neuropsychological battery. Neurology 1994, 44:609-614.
81. Wozniak J.R., Lim K.O. Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci. Biobehav. Rev. 2006, 30:762-774.
82. Yang Y.H., Lai C.L., Lin R.T., Tai C.T., Liu C.K. Cut-off values of blessed dementia rating scale and its clinical application in elderly Taiwanese. Kaohsiung J. Med. Sci. 2006, 22(8):377-384.
83. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov randomfield model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 2001, 20(1):45-57.
84. Zhang Y., Schuff N., Hahng G.H., Bayne W., Mori S., Schad L., Mueller S., Du A.T., Kramer J.H., Yaffe M.D., Chui H., Jagust W.J., Miller B.L., Weiner M.W. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007, 68:13-19.
85. Zhu X., Smith M.A., Honda K., Aliev G., Moreira P.I., Nunomura A., Casadesus G., Harris P.L., Siedlak S.L., Perry G. Vascular oxidative stress in Alzheimer's disease. J. Neurol. Sci. 2007, 257(1-2):240-246.